Oncotarget

Research Papers:

Zfra activates memory Hyal-2+ CD3- CD19- spleen cells to block cancer growth, stemness, and metastasis in vivo

Ming-Hui Lee _, Wan-Pei Su, Wan-Jen Wang, Sing-Ru Lin, Chen-Yu Lu, Yu-An Chen, Jean-Yun Chang, Shenq-Shyang Huang, Pei-Yi Chou, Siou-Ru Ye, Szu-Jung Chen, Huan He, Ting-Hsiu Liu, Ying-Tsen Chou, Li-Jin Hsu, Feng-Jie Lai, Shean-Jen Chen, Hoong-Chien Lee, David Kakhniashvili, Steven R. Goodman and Nan-Shan Chang

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:3737-3751. https://doi.org/10.18632/oncotarget.2895

Metrics: PDF 1342 views  |   HTML 1759 views  |   ?  


Abstract

Ming-Hui Lee1,*, Wan-Pei Su1,*, Wan-Jen Wang1,*, Sing-Ru Lin1,*, Chen-Yu Lu1,*, Yu-An Chen1,*, Jean-Yun Chang1, Shenq-Shyang Huang1, Pei-Yi Chou1, Siou-Ru Ye1, Szu-Jung Chen1, Huan He1, Ting-Hsiu Liu1, Ying-Tsen Chou2, Li-Jin Hsu3,4,*, Feng-Jie Lai5, Shean-Jen Chen6, Hoong-Chien Lee7, David Kakhniashvili8, Steven R. Goodman8, Nan-Shan Chang1,2,4,6,9

1Institute of Molecular Medicine, National Cheng Kung University Medical College, Tainan, Taiwan, ROC

2Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan, Taiwan, ROC

3Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University Medical College, Tainan, Taiwan, ROC

4Center of Infectious Disease and Signal Research, National Cheng Kung University, Tainan, Taiwan, ROC

5Department of Dermatology, Chi-Mei Medical Center, Tainan, Taiwan, ROC

6Advanced Optoelectronic Technology Center, National Cheng Kung University Medical College, Tainan, Taiwan, ROC

7Graduate Institute of Systems Biology and Bioinformatics, National Central University, Zhongli, Taiwan, ROC

8Institute of Biomedical Sciences and Technology, Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA

9Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA

*These authors have contributed equally to this work

Correspondence to:

Nan-Shan Chang, e-mail: nschang13827@gmail.com

Keywords: Zfra, skin cancer, melanoma, metastasis, stemness

Received: September 18, 2014     Accepted: December 11, 2014     Published: February 20, 2015

ABSTRACT

Zfra is a 31-amino-acid zinc finger-like protein, which participates in the tumor necrosis factor signaling. Here, we determined that when nude mice and BALB/c mice were pre-injected with nanogram levels of a synthetic Zfra1–31 or truncated Zfra4–10 peptide via tail veins, these mice became resistant to the growth, metastasis and stemness of melanoma cells, and many malignant cancer cells. The synthetic peptides underwent self-polymerization in phosphate-buffered saline. Alteration of the Ser8 phosphorylation site to Gly8 abolished Zfra aggregation and its-mediated cancer suppression in vivo. Injected Zfra peptide autofluoresced due to polymerization and was trapped mainly in the spleen. Transfer of Zfra-stimulated spleen cells to naïve mice conferred resistance to cancer growth. Zfra-binding cells, designated Hyal-2+ CD3- CD19- Z cells, are approximately 25–30% in the normal spleen, but are significantly downregulated (near 0–3%) in tumor-growing mice. Zfra prevented the loss of Z cells caused by tumors. In vitro stimulation or education of naïve spleen cells with Zfra allowed generation of activated Z cells to confer a memory anticancer response in naïve or cancer-growing mice. In particular, Z cells are abundant in nude and NOD-SCID mice, and can be readily activated by Zfra to mount against cancer growth.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2895